Filtros : "Soltani‐asl, Maryam" Limpar

Filtros



Refine with date range


  • Source: Molecular Biology Reports. Unidade: FMVZ

    Subjects: IMUNOTERAPIA, LINFÓCITOS T, NEOPLASIAS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AZIMNASAB‐SORKHABI, Parviz et al. Landscape of unconventional γδ T cell subsets in cancer. Molecular Biology Reports, v. 51, p. 1-13, 2024Tradução . . Disponível em: https://doi.org/10.1007/s11033-024-09267-1. Acesso em: 20 maio 2024.
    • APA

      Azimnasab‐sorkhabi, P., Soltani‐asl, M., Ekhtiyari, M. S., & Kfoury Junior, J. R. (2024). Landscape of unconventional γδ T cell subsets in cancer. Molecular Biology Reports, 51, 1-13. doi:10.1007/s11033-024-09267-1
    • NLM

      Azimnasab‐sorkhabi P, Soltani‐asl M, Ekhtiyari MS, Kfoury Junior JR. Landscape of unconventional γδ T cell subsets in cancer [Internet]. Molecular Biology Reports. 2024 ; 51 1-13.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s11033-024-09267-1
    • Vancouver

      Azimnasab‐sorkhabi P, Soltani‐asl M, Ekhtiyari MS, Kfoury Junior JR. Landscape of unconventional γδ T cell subsets in cancer [Internet]. Molecular Biology Reports. 2024 ; 51 1-13.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s11033-024-09267-1
  • Source: Human Cell. Unidade: FMVZ

    Subjects: IMUNOTERAPIA, LINFÓCITOS T, NEOPLASIAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AZIMNASAB‐SORKHABI, Parviz e SOLTANI‐ASL, Maryam e KFOURY JUNIOR, José Roberto. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells. Human Cell, v. 36, p. 1225-1232, 2023Tradução . . Disponível em: https://doi.org/10.1007/s13577-023-00893-8. Acesso em: 20 maio 2024.
    • APA

      Azimnasab‐sorkhabi, P., Soltani‐asl, M., & Kfoury Junior, J. R. (2023). Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells. Human Cell, 36, 1225-1232. doi:10.1007/s13577-023-00893-8
    • NLM

      Azimnasab‐sorkhabi P, Soltani‐asl M, Kfoury Junior JR. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells [Internet]. Human Cell. 2023 ; 36 1225-1232.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s13577-023-00893-8
    • Vancouver

      Azimnasab‐sorkhabi P, Soltani‐asl M, Kfoury Junior JR. Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells [Internet]. Human Cell. 2023 ; 36 1225-1232.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s13577-023-00893-8
  • Source: Molecular Biology Reports. Unidade: FMVZ

    Subjects: NEOPLASIAS, ENZIMAS, IMUNOSSUPRESSÃO

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AZIMNASAB‐SORKHABI, Parviz et al. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports, v. 50, p. 6133-6145, 2023Tradução . . Disponível em: https://doi.org/10.1007/s11033-023-08469-3. Acesso em: 20 maio 2024.
    • APA

      Azimnasab‐sorkhabi, P., Soltani‐asl, M., Yoshinaga, T. T., Dagli, M. L. Z., Gomes, C. de O. M. -S., & Kfoury Junior, J. R. (2023). Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports, 50, 6133-6145. doi:10.1007/s11033-023-08469-3
    • NLM

      Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Dagli MLZ, Gomes C de OM-S, Kfoury Junior JR. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment [Internet]. Molecular Biology Reports. 2023 ; 50 6133-6145.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s11033-023-08469-3
    • Vancouver

      Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Dagli MLZ, Gomes C de OM-S, Kfoury Junior JR. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment [Internet]. Molecular Biology Reports. 2023 ; 50 6133-6145.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s11033-023-08469-3
  • Source: Immunologic Research. Unidade: FMVZ

    Subjects: NEOPLASIAS MAMÁRIAS, IMUNOTERAPIA, ENZIMAS

    PrivadoAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AZIMNASAB‐SORKHABI, Parviz et al. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells. Immunologic Research, v. 71, p. 679-686, 2023Tradução . . Disponível em: https://doi.org/10.1007/s12026-023-09378-0. Acesso em: 20 maio 2024.
    • APA

      Azimnasab‐sorkhabi, P., Soltani‐asl, M., Yoshinaga, T. T., Gomes, C. de O. M. -S., & Kfoury Junior, J. R. (2023). IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells. Immunologic Research, 71, 679-686. doi:10.1007/s12026-023-09378-0
    • NLM

      Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Gomes C de OM-S, Kfoury Junior JR. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells [Internet]. Immunologic Research. 2023 ; 71 679-686.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s12026-023-09378-0
    • Vancouver

      Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Gomes C de OM-S, Kfoury Junior JR. IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells [Internet]. Immunologic Research. 2023 ; 71 679-686.[citado 2024 maio 20 ] Available from: https://doi.org/10.1007/s12026-023-09378-0

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024